Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Review ArticleClinical StudiesR

Intestinal Macrophages Involved in the Homeostasis of the Intestine Have the Potential for Responding to LPS

NORIKO YOSHIOKA, YOSHIE TANIGUCHI, AYA YOSHIDA, KAZUE NAKATA, TAKASHI NISHIZAWA, HIROYUKI INAGAWA, CHIE KOHCHI and GEN-ICHIRO SOMA
Anticancer Research November 2009, 29 (11) 4861-4865;
NORIKO YOSHIOKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIE TANIGUCHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AYA YOSHIDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUE NAKATA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKASHI NISHIZAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROYUKI INAGAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIE KOHCHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEN-ICHIRO SOMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sma5628{at}tokushima.bunri-u.ac.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Recently, there has been interest in the tertiary functions of food, those that maintain human health. Moreover, lipopolysaccharides (LPS), which are components of Gram-negative bacteria, have been found to be highly effective in activating innate immunity and have been rediscovered as new functional food materials. In this review, we discuss the significance of LPS as a food component with reference to these tertiary functions based on recent findings. There is special emphasis on the plasticity of responses to LPS by intestinal macrophages. According to the macrophage-network theory, local macrophages cooperate with other tissue macrophages. For this reason, this review also discusses the possibility that information is transferred throughout the body from intestinal macrophages.

  • Intestinal macrophage
  • LPS
  • homeostasis
  • CD14
  • IgA
  • review

Food supplies both nutrients and may provide a tertiary function in regulating health. Immune regulation of these tertiary functions may prevent certain diseases or maintain and augment health. In advanced countries, it is hoped that these tertiary functions can be developed to counteract problems of lifestyle-related diseases such as hyperlipidemia, diabetes and cancer, and problems related to the transition to an aging society.

LPS derived from Gram-negative bacteria contained in food can regulate immunity. LPS in food is considered to show its function through residential macrophage in the intestine.

Macrophages are present in every tissue of the human body where they are referred to as tissue macrophages. When resident tissue macrophages encounter foreign substances, they produce cytokines and present antigens for transfer signals to neighboring macrophages (1). Intestinal macrophages are found in the lamina propria of the intestinal mucosa (2) where they are in close contact with the external environmental. They make up the largest pool of macrophages present in manuals (3) and are thought to be able to recognize functional foods. Therefore, we believe homeostasis is regulated in part by this response of intestinal macrophages.

LPS is present in some foods and plays a role in regulating immunity. The LPS in foods functions through the actions of the resident intestinal macrophage in the intestine. LPS is the strongest macrophage-activating substance of known immunopotentiators. Food contains about 0.16 to 600 ng/g of LPS (4). We believe that these LPS function to regulate immunity after recognition by intestinal macrophages.

In this review, we discuss the significance of LPS as a food component that has the tertiary function of regulation. Recent findings indicate that there is plasticity in the responses to LPS by intestinal macrophages. Based on the macrophage network theory, local macrophages cooperate with other tissue macrophages. This may allow information transfer to the whole body from intestinal macrophages

Characteristics of the Intestinal Macrophages Present in the Lamina Propria Mucosa of the Digestive Tract

It is well known that cytokines such as interferon (IFN) α, tumor necrosis factor (TNF), and interleukin (IL)-1 are secreted in response to LPS stimulation by tissue macrophages in the abdominal cavity, spleen, alveolus, etc. CD14 and toll-like receptor (TLR) 4 exist on the cellular membrane of macrophages and recognize LPS (5). Signals are transmitted to adapter molecules such as MyD88 to activate transcription factors (6, 7). This characteristic is considered to be common in macrophages. However, it is now clear that intestinal macrophages, have different characteristics.

Intestinal macrophages express markers for CD33, CD68, and CD13 in the same way as monocytes and other tissue macrophages (8, 9). However, unlike other tissue macrophages, intestinal macrophages do not express CD14 or TLR4 on their membranes (9). It has been reported that intestinal macrophages do not secrete cytokines after LPS stimulation (10). For this reason they are considered to be non-responsive to LPS. It has also been reported that intestinal macrophages do not express either the Fc receptor for IgA (CD89) or IgG (CD16, CD32, CD42), or receptor complexes such as CR3 (CD11b/CD18) or CR4 (CD11c/CD18) other than LPS receptors (9, 11-14). In addition to the suppression of the expression of receptors, it was also reported that intestinal macrophages do not produce IL-12, which is an inflammatory cytokine. Instead they produce IL-10, which exhibits anti-inflammatory properties (15). We compared the expression of mRNA between intestinal macrophages and peritoneal macrophages using a DNA array. The expression of ficolin- and mannose-binding lectins (MBL) (which are known as defense lectins) (16) recognizes pathogen-associated molecular patterns (PAMPs); this is less than in intestinal macrophages (Table I). From these results, intestinal macrophages are believed to possess the ability to eliminate foreign substances and to regulate the mechanism of inflammation. Their responses are different from those of other tissue macrophages.

However, CD14, which was not observed as being expressed on the membrane of resident intestinal macrophages, recently was recently reported to exist intracellularly as a protein (17). In culture of intestinal macrophage on IgA-coated wells, expression of CD14 was induced on the cellular membranes (18). Furthermore, the induction of TNF occurred when these cells were stimulated with LPS (10). This suggests the possibility of plasticity: under certain conditions when CD14 in intestinal macrophage is expressed on the membrane, intestinal macrophages show LPS responsiveness.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Ratio of mRNA expression by mouse intestinal macrophages when compared to mouse peritoneal macrophages.

From the above, we believe that although intestinal macrophages appear to be non-responsive to LPS, they are capable of recognizing the LPS. This is the way that LPS leads to maintaining homeostasis of the intestine through intestinal macrophages.

LPS as a Component of Functional Foods

LPS as a component of the cellular wall of Gram-negative bacteria is commonly referred to as an endotoxin. Currently, there are only a few reports that describe the usefulness of LPS including adding it to food. Nevertheless, it is present in many foods and is reported to be contained in significant quantities in wheat bran (132 μg/human) and malt (180 μg/human), both known as health foods (4). Gram-negative bacteria are known to be symbiotic on many food crops such as rice, sweet potatoes, apples and pears (19). Furthermore, fermentation by Gram-negative bacteria is necessary for the production of Nata de Coco and Caspian Sea yoghurt, so LPS is contained in these foods. Thus, people have been unknowingly consuming LPS and may have benefited from it. These are several reports that provide concrete examples of LPS as an important molecule for homeostasis of the intestine. First there is a study on the survival rate and the pathology of mice with ulcerative colitis caused by sodium dextran sulfate (DSS) administered after the elimination of enterobacteria by preadministration of antibiotics (20). The results showed there was no survival 12 days after DSS was administered alone. By contrast, in the group of mice administered LPS in addition to DSS, the survival rate was 100%. Significantly favorable results were also obtained related to the pathology of the ulcerative colitis (in loss in body weight and bloody stool).

RegIIIγ is a lectin which has the ability to suppress the activity of Gram-positive bacteria (21). It is secreted from intestinal epithelial or paneth cells and is induced by TLR4 MyD88-mediated signals from intestinal symbiotic bacteria (21, 22). It is reported that the production of RegIIIγ was inhibited after the administration of antibiotics and that vancomycin-resistant bacteria proliferated. But this proliferation of vancomysin-resistant bacteria was suppressed when LPS was administered in addition to the antibiotics (23). Accordingly, in our comparative analysis between intestinal macrophages and peritoneal macrophages using DNA array analysis, RegIIIγ was observed to have higher expression in intestinal macrophages than in peritoneal macrophages (Table I). In other words, our experimental results suggested that intestinal macrophages may produce RegIIIγ. We presume that intestinal macrophages produce RegIIIγ after recognizing LPS through TLR4.

Recognition of LPS in Intestinal Macrophage

Current findings indicate that resident intestinal macrophages, which do not respond to LPS, cannot acquire responsiveness to LPS without contact with IgA in the intestinal tissue. Normally, resident intestinal macrophages are present in lamina propria mucosa (2), while IgA is produced and secreted as a dimer by IgA plasma cells in the lamina propria mucosa of the intestine (14). This dimeric IgA is formed by combining with secretory component (SC) in the epithelial cells in the intestinal mucosa; it is secreted in the mucus of the surface layer of mucosa and contributes to immunity on the mucosa (24). Thus, intestinal macrophages and IgA are separated by intestinal epithelial cells and are not in direct contact with each other.

The intestine is always exposed to antigens derived from the diet and resident enterobacteria. While mucosal epithelial cells do not cause severe inflammation by these antigens, they produce antimicrobial peptides or chemokines to protect the intestine from infection. This phylaxis requires that antigens be moved effectively in the lymphatic tissues related to the mucosa such as Peyer's patches (25). For this purpose, M cells actively take in antigens on the mucosa by transcytosis and deliver them to antigen-presenting cells that are present immediately under the epithelium (26). If this antigen is opsonized by IgA, it is possible that responsiveness to LPS is obtained by the induction of expression of CD14 or TLR4 on the membrane in macrophages that are present directly under the epithelium and that recognize the IgA.

However, it has already been reported that CD89, a molecule that recognizes IgA, was not expressed in intestinal macrophages (9, 11, 27). For this reason, it has been suggested that intestinal macrophages may express IgA receptors other than CD89, such as the Fc receptor to IgA or IgM (Fcα/μR) (28, 29), polymeric Ig receptor (pIgR) (30, 31), CD71 (32), and asialoglycoprotein receptor (ASGPR). In fact, pIgR was observed to have higher expression in intestinal macrophages than in peritoneal macrophages (Table I). Furthermore, the neonatal immunoglobulin receptor (FcRn) is reported to be expressed in intestinal macrophages (33-35). It is not yet clear which receptor recognizes IgA and induces membrane expression of CD14, but it is believed that there are receptors in the intestinal macrophages that are involved in membrane expression of CD14 (Figure 1).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Hypothetical process responsible for intestinal macrophage contact with LPS. IgA-producing plasma cells produce IgA in the intestinal lamina propria. Secretory IgA (sIgA) is secreted in the lumen (sIgA-opsonized antigens). Transcytosis of opsonized antigens occurs in M cells. Intestinal macrophages then recognize opsonized antigens from the IgA and are induced to express CD14. Finally, the intestinal macrophages recognize the presence of invasive LPS in the intestinal lamina propria.

Systemic Effect Provoked by Intestinal Macrophages in the Digestive Tract

As mentioned above, LPS recognition by intestinal macrophages does more than just maintain homeostasis of the intestine. There is a report of a signal-transfer system from local activated macrophages to other macrophages by cell-to-cell contact. This is called a ‘macrophage network’ (36). It is thought that the macrophage network is the control system for homeostasis.

It is well known that intestinal macrophages are not activated by LPS. But they are in close contact with the external environmental. Moreover, the lamina propria contains the largest reservoir of macrophages in the body. Under these circumstances, it is thought that the intestinal macrophages become the cells that dispatch information through the macrophage network.

LPS recognition by intestinal macrophages is believed to have an effect that extends beyond the maintenance of homeostasis of the intestine. Further study is required to clarify the molecular evidence for interaction of LPS with intestinal macrophages.

Acknowledgements

This work was supported in part by grants-in-aid for “City Area Program (Developmed Stage, Takamatsu Area)” from the Ministry of Education, Sport, Science and Technology, Japan.

  • Received April 28, 2009.
  • Revision received July 22, 2009.
  • Accepted September 1, 2009.
  • Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Lewis C,
    2. McGee JOD
    : The Macrophage: The Natural Immune System. IRL Press at Oxford University Press, 1992.
  2. ↵
    1. Mahida YR,
    2. Patel S,
    3. Gionchetti P,
    4. Vaux D,
    5. Jewell DP
    : Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut 30: 826-834, 1989.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Lee SH,
    2. Starkey PM,
    3. Gordon S
    : Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80. J Exp Med 161: 475-489, 1985.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Inagawa H,
    2. Nishizawa I,
    3. Yoshioka N,
    4. Taniguchi Y,
    5. Kohchi C,
    6. Soma GI
    : Preventative and therapeutic potential of lipopolysaccharide derived from edible Gram-negative bacteria to various diseases. Curr Drug Ther 3: 26-30, 2008.
    OpenUrl
  5. ↵
    1. Triantafilou M,
    2. Triantafilou K
    : Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 23: 301-304, 2002.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Palsson-McDermott EM,
    2. O'Neill LA
    : Signal transduction by the lipopolysaccharide receptor, toll-like receptor-4. Immunology 113: 153-162, 2004.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Akira S,
    2. Takeda K,
    3. Kaisho T
    : Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2: 675-680, 2001.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Kamada N,
    2. Hisamatsu T,
    3. Okamoto S,
    4. Chinen H,
    5. Kobayashi T,
    6. Sato T,
    7. Sakuraba A,
    8. Kitazume MT,
    9. Sugita A,
    10. Koganei K,
    11. Akagawa KS,
    12. Hibi T
    : Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest 118: 2269-2280, 2008.
    OpenUrlPubMed
  9. ↵
    1. Smith PD,
    2. Smythies LE,
    3. Mosteller-Barnum M,
    4. Sibley DA,
    5. Russell MW,
    6. Merger M,
    7. Sellers MT,
    8. Orenstein JM,
    9. Shimada T,
    10. Graham MF,
    11. Kubagawa H
    : Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 167: 2651-2656, 2001.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Nakata K,
    2. Inagawa H,
    3. Nishizawa T,
    4. Honda T,
    5. Kohchi C,
    6. Tonomoto Y,
    7. Yoshimura H,
    8. Nagasue N,
    9. Natori S,
    10. Terada H,
    11. Soma G
    : Inherent potential for production of tumor necrosis factor-alpha by human intestinal macrophages. Int J Colorectal Dis 21: 339-347, 2006.
    OpenUrlPubMed
  11. ↵
    1. Smith PD,
    2. Ochsenbauer-Jambor C,
    3. Smythies LE
    : Intestinal macrophages: unique effector cells of the innate immune system. Immunol Rev 206: 149-159, 2005.
    OpenUrlCrossRefPubMed
    1. Smythies LE,
    2. Sellers M,
    3. Clements RH,
    4. Mosteller-Barnum M,
    5. Meng G,
    6. Benjamin WH,
    7. Orenstein JM,
    8. Smith PD
    : Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115: 66-75, 2005.
    OpenUrlCrossRefPubMed
    1. Grimm MC,
    2. Pavli P,
    3. Van de Pol E,
    4. Doe WF
    : Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa — implications for pathogenesis. Clin Exp Immunol 100: 291-297, 1995.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Schenk M,
    2. Mueller C
    : Adaptations of intestinal macrophages to an antigen-rich environment. Semin Immunol 19: 84-93, 2007.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Kamada N,
    2. Hisamatsu T,
    3. Okamoto S,
    4. Sato T,
    5. Matsuoka K,
    6. Arai K,
    7. Nakai T,
    8. Hasegawa A,
    9. Inoue N,
    10. Watanabe N,
    11. Akagawa KS,
    12. Hibi T
    : Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol 175: 6900-6908, 2005.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Endo Y,
    2. Liu Y,
    3. Kanno K,
    4. Takahashi M,
    5. Matsushita M,
    6. Fujita T
    : Identification of the mouse H-ficolin gene as a pseudogene and orthology between mouse ficolins A/B and human L-/M-ficolins. Genomics 84: 737-744, 2004.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Nakata K,
    2. Inagawa H,
    3. Nishizawa T,
    4. Kohchi C,
    5. Soma GI
    : Specific messenger RNA expression for signal transduction molecules by lipopolysaccharide in intestinal macrophages. Clin Exp Immunol 143: 484-493, 2006.
    OpenUrlPubMed
  16. ↵
    1. Yoshioka N,
    2. Taniguchi Y,
    3. Yoshida A,
    4. Nakata K,
    5. Nishizawa T,
    6. Inagawa H,
    7. Kohchi C,
    8. Soma G
    : Intracellular localization of CD14 protein in intestinal macrophages. Anticancer Res 29: 865-869, 2009.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Nunes C,
    2. Usall J,
    3. Teixidó N,
    4. Viñas I
    : Biological control of postharvest pear diseases using a bacterium, Pantoea agglomerans CPA-2. Int J Food Microbiol 70: 53-61, 2001.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Rakoff-Nahoum S,
    2. Paglino J,
    3. Eslami-Varzaneh F,
    4. Edberg S,
    5. Medzhitov R
    : Recognition of commensal micoflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-41, 2004.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Cash HL,
    2. Whitham CV,
    3. Behrendt CL,
    4. Hooper LV
    : Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313: 1126-30, 2006.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Brandl K,
    2. Plitas G,
    3. Schnabl B,
    4. DeMatteo RP,
    5. Pamer EG
    : MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J Exp Med 204: 1891-900, 2007.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Brandl K,
    2. Plitas G,
    3. Mihu CN,
    4. Ubeda C,
    5. Jia T,
    6. Fleisher M,
    7. Schnabl B,
    8. DeMatteo RP,
    9. Pamer EG
    : Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455: 804-807, 2008.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Wines BD,
    2. Hogarth PM
    , IgA receptors in health and disease. Tissue Antigens 68: 103-114, 2006.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Tyrer P,
    2. Foxwell AR,
    3. Cripps AW,
    4. Apicella MA,
    5. Kyd JM
    : Microbial pattern recognition receptors mediate M-cell uptake of a gram-negative bacterium. Infect Immun 74: 625-631, 2006.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Sansonetti PJ
    : War and peace at mucosal surfaces. Nat Rev Immunol 4: 953-964, 2004.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Hamre R,
    2. Farstad IN,
    3. Brandtzaeg P,
    4. Morton HC
    : Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR gamma chain on myeloid cells in blood and tissue. Scand J Immunol 57: 506-516, 2003.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Shibuya A,
    2. Sakamoto N,
    3. Shimizu Y,
    4. Shibuya K,
    5. Osawa M,
    6. Hiroyama T,
    7. Eyre HJ,
    8. Sutherland GR,
    9. Endo Y,
    10. Fujita T,
    11. Miyabayashi T,
    12. Sakano S,
    13. Tsuji T,
    14. Nakayama E,
    15. Phillips JH,
    16. Lanier LL,
    17. Nakauchi H
    : Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol 1: 441-446, 2000.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Sakamoto N,
    2. Shibuya K,
    3. Shimizu Y,
    4. Yotsumoto K,
    5. Miyabayashi T,
    6. Sakano S,
    7. Tsuji T,
    8. Nakayama E,
    9. Nakauchi H,
    10. Shibuya A
    : A novel Fc receptor for IgA and IgM is expressed on both hematopoietic and non-hematopoietic tissues. Eur J Immunol 31: 1310-1316, 2001.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Kaetzel CS
    : The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol Rev 206: 83-99, 2005.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Norderhaug IN,
    2. Johansen FE,
    3. Schjerven H,
    4. Brandtzaeg P
    : Regulation of the formation and external transport of secretory immunoglobulins. Crit Rev Immunol 19: 481-508, 1999.
    OpenUrlPubMed
  30. ↵
    1. Woof JM,
    2. Kerr MA
    : The function of immunoglobulin A in immunity. J Pathol 208: 270-282, 2006.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Hu CB,
    2. Lee EY,
    3. Hewitt JE,
    4. Baenziger JU,
    5. Mu JZ,
    6. DeSchryver-Kecskemeti K,
    7. Alpers DH
    : The minor components of the rat asialoglycoprotein receptor are apically located in neonatal enterocytes. Gastroenterology 101: 1477-1487, 1991.
    OpenUrlPubMed
    1. Rifai A,
    2. Fadden K,
    3. Morrison SL,
    4. Chintalacharuvu KR
    : The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes. J Exp Med 191: 2171-2182, 2000.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    1. Valladeau J,
    2. Duvert-Frances V,
    3. Pin JJ,
    4. Kleijmeer MJ,
    5. Ait-Yahia S,
    6. Ravel O,
    7. Vincent C,
    8. Vega F Jr.,
    9. Helms A,
    10. Gorman D,
    11. Zurawski SM,
    12. Zurawski G,
    13. Ford J,
    14. Saeland S
    : Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J Immunol 167: 5767-5774, 2001.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Kohchi C,
    2. Inagawa H,
    3. Hino M,
    4. Oda M,
    5. Nakata K,
    6. Yoshida A,
    7. Hori H,
    8. Terada H,
    9. Makino K,
    10. Takiguchi K,
    11. Soma G
    : Utilization of macrophages in anticancer therapy: the macrophage network theory. Anticancer Res 24: 3311-3320, 2004.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 29, Issue 11
November 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Intestinal Macrophages Involved in the Homeostasis of the Intestine Have the Potential for Responding to LPS
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
9 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Intestinal Macrophages Involved in the Homeostasis of the Intestine Have the Potential for Responding to LPS
NORIKO YOSHIOKA, YOSHIE TANIGUCHI, AYA YOSHIDA, KAZUE NAKATA, TAKASHI NISHIZAWA, HIROYUKI INAGAWA, CHIE KOHCHI, GEN-ICHIRO SOMA
Anticancer Research Nov 2009, 29 (11) 4861-4865;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Intestinal Macrophages Involved in the Homeostasis of the Intestine Have the Potential for Responding to LPS
NORIKO YOSHIOKA, YOSHIE TANIGUCHI, AYA YOSHIDA, KAZUE NAKATA, TAKASHI NISHIZAWA, HIROYUKI INAGAWA, CHIE KOHCHI, GEN-ICHIRO SOMA
Anticancer Research Nov 2009, 29 (11) 4861-4865;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Characteristics of the Intestinal Macrophages Present in the Lamina Propria Mucosa of the Digestive Tract
    • LPS as a Component of Functional Foods
    • Recognition of LPS in Intestinal Macrophage
    • Systemic Effect Provoked by Intestinal Macrophages in the Digestive Tract
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Induction of Nitric Oxide Production in RAW264.7 Cells under Serum-free Conditions by O-antigen Polysaccharide of Lipopolysaccharide
  • Functional Characterization of Lipopolysaccharide derived from Symbiotic Bacteria in Rice as a Macrophage-activating Substance
  • Google Scholar

More in this TOC Section

  • Real-world Analysis of Treatment Patterns, Clinical Outcomes, and Molecular Profiling in Advanced Biliary Tract Cancer
  • Post-progression Nutritional and Immune Status Determines Survival After First-line Chemotherapy in Unresectable Advanced Gastric Cancer
  • Factors Associated With Nonadherence to S-1 in Docetaxel+S-1(DS) Therapy, an Adjuvant Treatment for Gastric Cancer
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire